Bas W.G. van Rhijn

1.4k total citations
36 papers, 821 citations indexed

About

Bas W.G. van Rhijn is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Bas W.G. van Rhijn has authored 36 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Surgery, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Bas W.G. van Rhijn's work include Bladder and Urothelial Cancer Treatments (20 papers), Urinary and Genital Oncology Studies (9 papers) and Urological Disorders and Treatments (9 papers). Bas W.G. van Rhijn is often cited by papers focused on Bladder and Urothelial Cancer Treatments (20 papers), Urinary and Genital Oncology Studies (9 papers) and Urological Disorders and Treatments (9 papers). Bas W.G. van Rhijn collaborates with scholars based in Netherlands, Germany and United States. Bas W.G. van Rhijn's co-authors include Theodorus van der Kwast, Ellen C. Zwarthoff, Wim J. Kirkels, Irene Lurkin, François Radvanyi, Simon Horenblas, Henk G. van der Poel, Axel Bex, Erik van Werkhoven and Rosa S. Djajadiningrat and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Bas W.G. van Rhijn

30 papers receiving 805 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bas W.G. van Rhijn Netherlands	12	610	243	164	155	123	36	821
Ja Yoon Ku South Korea	13	190 0.3×	115 0.5×	139 0.8×	57 0.4×	46 0.4×	49	438
C. Lebâcle France	12	227 0.4×	77 0.3×	185 1.1×	63 0.4×	74 0.6×	47	408
Iwona Skoneczna Poland	10	449 0.7×	80 0.3×	147 0.9×	58 0.4×	192 1.6×	22	589
Akinori Nukui Japan	13	116 0.2×	113 0.5×	223 1.4×	31 0.2×	211 1.7×	50	501
Kelly J. Manahan United States	14	187 0.3×	92 0.4×	69 0.4×	19 0.1×	111 0.9×	46	563
Pridvi Kandagatla United States	9	87 0.1×	109 0.4×	105 0.6×	57 0.4×	178 1.4×	29	423
G.N. Thalmann Switzerland	7	332 0.5×	111 0.5×	147 0.9×	144 0.9×	91 0.7×	22	539
Thomas A. Longo United States	11	185 0.3×	81 0.3×	90 0.5×	46 0.3×	178 1.4×	23	425
V. Merz Switzerland	10	292 0.5×	147 0.6×	174 1.1×	195 1.3×	80 0.7×	16	558
Yousheng Yao China	13	285 0.5×	59 0.2×	87 0.5×	190 1.2×	62 0.5×	35	520

Countries citing papers authored by Bas W.G. van Rhijn

Since Specialization

Citations

This map shows the geographic impact of Bas W.G. van Rhijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bas W.G. van Rhijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bas W.G. van Rhijn more than expected).

Fields of papers citing papers by Bas W.G. van Rhijn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bas W.G. van Rhijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bas W.G. van Rhijn. The network helps show where Bas W.G. van Rhijn may publish in the future.

Co-authorship network of co-authors of Bas W.G. van Rhijn

This figure shows the co-authorship network connecting the top 25 collaborators of Bas W.G. van Rhijn. A scholar is included among the top collaborators of Bas W.G. van Rhijn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bas W.G. van Rhijn. Bas W.G. van Rhijn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

KleinJan, Gijs H., Teele Kuusk, Robert M. Verdijk, et al.. (2025). Sentinel lymph node staging in urological cancer surgery: advances in imaging, intra‐operative detection and translational research. British Journal of Urology. 136(6). 979–989. 1 indexed citations

Dijk, Nick van, Daniël J. Vis, Bram van den Broek, et al.. (2025). Final clinical analysis of pre-operative ipilimumab and nivolumab in locally advanced urothelial cancer and exploration of tumor-draining lymph node composition: The NABUCCO trial. European Journal of Cancer. 229. 115731–115731.

Lijnen, Roger, Esther Wit, Thierry N. Boellaard, et al.. (2025). Routine annual imaging does not aid in diagnosing new functional complications more than five years after RC with ileal conduit. World Journal of Urology. 43(1). 539–539.

Claps, Francesco, Gianluca Giannarini, Nicola Pavan, et al.. (2024). The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current Literature. Journal of Clinical Medicine. 13(15). 4349–4349. 18 indexed citations

Gil-Jimenez, Alberto, Nick van Dijk, Joris L. Vos, et al.. (2024). Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors. Nature Communications. 15(1). 2538–2538. 10 indexed citations

Wilpe, Sandra van, Iris M. Seignette, Alberto Gil-Jimenez, et al.. (2024). Platinum-Based Chemotherapy Induces Opposing Effects on Immunotherapy Response-Related Spatial and Stromal Biomarkers in the Bladder Cancer Microenvironment. Clinical Cancer Research. 30(18). 4227–4239. 3 indexed citations

Dijk, Nick van, Maurits L. van Montfoort, Iris M. Seignette, et al.. (2024). Clinical efficacy and biomarker analysis of pre-operative ipilimumab plus nivolumab in stage III urothelial cancer: The NABUCCO trial update.. Journal of Clinical Oncology. 42(16_suppl). 4593–4593. 1 indexed citations

Vries, Hielke M. de, Vincent van der Noort, Simon Horenblas, et al.. (2024). Penile cancer care in the Netherlands: increased incidence, centralisation, and improved survival. British Journal of Urology. 133(5). 596–603. 8 indexed citations

Gužvić, Miodrag, Bas W.G. van Rhijn, Maximilian Haas, et al.. (2023). Body Composition as a Comorbidity-Independent Predictor of Survival following Nephroureterectomy for Urothelial Cancer of the Upper Urinary Tract. Cancers. 15(2). 450–450. 4 indexed citations

10.

Rossum, Huub H. van, Thierry N. Boellaard, Elise M. Bekers, et al.. (2023). Clinical value of preoperative serum tumor markers CEA, CA19-9, CA125, and CA15-3 in surgically treated urachal cancer. Urologic Oncology Seminars and Original Investigations. 41(7). 326.e17–326.e24. 4 indexed citations

11.

Gil-Jimenez, Alberto, Alberto Contreras‐Sanz, Daniël J. Vis, et al.. (2022). Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer. European Urology. 83(4). 313–317. 26 indexed citations

12.

Montfoort, Maurits L. van, Nick van Dijk, Ingrid Hofland, et al.. (2021). A Serendipitous Preoperative Trial of Combined Ipilimumab Plus Nivolumab for Localized Prostate Cancer. Clinical Genitourinary Cancer. 20(2). e173–e179. 1 indexed citations

13.

Vos, Kristan E. van der, Daniël J. Vis, Woonyoung Choi, et al.. (2020). Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer. Scientific Reports. 10(1). 10952–10952. 10 indexed citations

14.

Jong, Joep J. de, Yang Liu, A. Gordon Robertson, et al.. (2019). Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis. Genome Medicine. 11(1). 60–60. 44 indexed citations

15.

Kuusk, Teele, Maarten L. Donswijk, Renato A. Valdés Olmos, et al.. (2018). An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors. EJNMMI Research. 8(1). 105–105. 6 indexed citations

16.

Putte, Elisabeth E. Fransen van de, Liesbeth L. de Wall, Erik van Werkhoven, et al.. (2017). Endo-Urological Techniques for Benign Uretero-Ileal Strictures Have Poor Efficacy and Affect Renal Function. Urologia Internationalis. 100(1). 18–24. 8 indexed citations

17.

Mertens, Laura S., R.P. Meijer, Wim Meinhardt, et al.. (2014). 787 Occult lymph node metastases in patients with muscle invasive bladder cancer: Incidence after neoadjuvant chemotherapy and cystectomy versus cystectomy alone. European Urology Supplements. 13(1). e787–e787. 2 indexed citations

18.

Djajadiningrat, Rosa S., Erik van Werkhoven, Wim Meinhardt, et al.. (2013). Penile Sparing Surgery for Penile Cancer—Does it Affect Survival?. The Journal of Urology. 192(1). 120–126. 87 indexed citations

19.

Rhijn, Bas W.G. van, Bharati Bapat, Theodorus van der Kwast, et al.. (2009). 308 THE FGFR3 MUTATION IS RELATED TO FAVORABLE PT1 BLADDER CANCER. European Urology Supplements. 8(4). 197–197. 10 indexed citations

20.

Vis, André N., Bas W.G. van Rhijn, Marinus A. Noordzij, Fritz H. Schröder, & Theodorus van der Kwast. (2002). Value of tissue markers p27^kip1, MIB‐1, and CD44s for the pre‐operative prediction of tumour features in screen‐detected prostate cancer. The Journal of Pathology. 197(2). 148–154. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact